Cerbios-Pharma Acquired by HAS with 65 Equity Partners' Backing
Deal News | Mar 31, 2025 | Ropes & Gray
Ropes & Gray advised 65 Equity Partners in the acquisition of Cerbios-Pharma by HAS Healthcare Advanced Synthesis. Both companies, based in Switzerland, are leaders in the pharmaceutical industry, and this merger creates a highly integrated leader in the Contract Development and Manufacturing Organisation (CDMO) sector. With 65 Equity Partners acquiring a 40% stake, the merger partners aim to drive growth and innovation in complex therapies. The Ropes & Gray team, led by John Newton, included specialists from various legal fields to provide comprehensive support through the acquisition process.
Sectors
- Pharmaceuticals
- Contract Development and Manufacturing Organisation (CDMO)
Geography
- Switzerland – Both Cerbios-Pharma and HAS Healthcare Advanced Synthesis are based in Switzerland and operate globally.
- Global – The companies involved in the merger sell their products and services globally, implying a worldwide reach.
Industry
- Pharmaceuticals – The industry involves companies engaged in the development, production, and marketing of drugs and therapies, which is the focus of HAS and Cerbios-Pharma.
- Contract Development and Manufacturing Organisation (CDMO) – This sector involves companies that provide comprehensive services from drug development through to manufacturing, as is the new direction for the combined Cerbios-Pharma and HAS.
Financials
- 40% – 65 Equity Partners becomes a c.40% shareholder in the combined company.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| Ropes & Gray | Legal Advisor | Company | A global law firm advising on the acquisition process. |
| Cerbios-Pharma SA | Target Company | Company | A Swiss company manufacturing chemical and biological APIs. |
| HAS Healthcare Advanced Synthesis SA | Bidding Company | Company | An international developer and producer of active pharmaceutical ingredients. |
| 65 Equity Partners | Investor/PE firm | Company | A global investment firm backing the merger and acquiring a 40% stake in the new entity. |
| Braglia Family | Majority Owner | People | Retain majority ownership in the merged entity. |